Sputum

AFB-Antibiogram for MTB Complex – Linezolid

Test Overview

The AFB-Antibiogram for Mycobacterium tuberculosis (MTB) Complex – Linezolid is a specialized drug susceptibility test used to determine whether the tuberculosis (TB) bacteria are sensitive or resistant to Linezolid, an important second-line anti-tubercular medication. This test helps clinicians select the most effective treatment regimen, especially in cases of drug-resistant tuberculosis.

Why is this Test Performed?

• To assess susceptibility of MTB complex to Linezolid.
• To support the management of multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
• To guide personalized anti-tubercular therapy.
• To monitor resistance patterns in tuberculosis infections.
• To improve treatment outcomes by selecting effective medications.

When is the Test Recommended?

• Confirmed tuberculosis cases requiring drug susceptibility testing.
• Patients with MDR-TB or suspected drug-resistant TB.
• Individuals not responding adequately to standard anti-TB treatment.
• Recurrent or relapsed tuberculosis infections.
• Cases where treatment optimization is necessary.

Sample Required

• Culture isolate of Mycobacterium tuberculosis complex obtained from clinical specimens.
• Sample type may originate from sputum, bronchoalveolar lavage (BAL), tissue, body fluids, or other relevant specimens as directed by the physician.

Test Method

• Phenotypic Drug Susceptibility Testing (DST) or validated molecular susceptibility assessment methods.
• Determines whether MTB isolates are Sensitive (Susceptible) or Resistant to Linezolid.

Understanding the Results

Sensitive (Susceptible)

• The tuberculosis bacteria are likely to respond to Linezolid therapy.
• Linezolid may be included in the treatment regimen as recommended by the treating physician.

Resistant

• The MTB strain demonstrates reduced or absent response to Linezolid.
• Alternative medications may be considered to ensure effective treatment.

Clinical Significance

Linezolid is a critical component in the treatment of resistant tuberculosis. Accurate susceptibility testing helps:

• Optimize TB treatment strategies.
• Prevent ineffective therapy.
• Reduce the risk of treatment failure.
• Limit the development and spread of drug-resistant TB.
• Improve patient outcomes through targeted therapy.

Preparation

No specific patient preparation is required. The test is performed on cultured MTB isolates obtained from clinical specimens.

Turnaround Time

Typically depends on culture growth and laboratory processing protocols.

Disclaimer

Test results should be interpreted by a qualified healthcare professional in conjunction with clinical findings, patient history, radiological investigations, and other laboratory results.